C. Arendrup, Danish Fungaemia Study Group; Statens Serum Inst., Copenhagen, Denmark. Yamagishi, H. Mikamo; Aichi Med. Univ., Aichi, Japan. M-326

56 SCIENTIFIC SESSIONS September 9-12 | M-314 Geographic Distribution and Co-Morbidities of Cryptococcal Meningitis in the U.S., 1997-2009

V. Pyrgos, A. E. Seitz , R. Prevots, P. R. Williamson; NIH, Bethesda, MD. M-315

Electronic Surveillance of Invasive Fungal Diseases in Hema- tology-Oncology Patients Using Natural Language Processing of Computed Tomography Reports: Towards Real-Time Prospective Surveillance

M. Ananda-Rajah

1 , D. Martinez 2 , H. Suominen 3 , K. Thursky, FRACP 4 , M. Slavin, FRACP 4 , L. Cavedon 2 ; 1 Alfred Hlth., Melbourne, Australia, 2 NICTA, Melbourne, Australia, 3 NICTA, Canberra, Australia, 4 Melbourne Hlth., Melbourne, Australia. M-316 Molecular Epidemiology and Fluconazole Susceptibility of Candida glabrata Candidemia at a University Affiliated Medical Center

N. D. Beyda

1,2 , A. Kilic Scientist 1 , M. J. Alam 1 , T. M. Lasco 2 , K. W. Garey 1,2 ; 1 Univ. of Houston Coll. of Pharmacy, Houston, TX, 2 St. Luke’s Episcopal Hosp., Houston, TX. M-317 Candidemia in Internal Medicine Wards iIMW: Epidemiol- ogy, Time to Initiate Antifungal Treatment and Outcome

M. Bassetti

1 , E. Righi 1 , E. Nicco 2 , L. Taramasso 2 , C. Viscoli 2 ; 1 Santa Maria Misericordia Hosp., Udine, Italy, 2 San Martino Hosp., Genova, Italy. M-318 National Surveillance of Fungemia in Denmark 2010-11

M. C. Arendrup, Danish Fungaemia Study Group; Statens Serum Inst., Copenhagen, Denmark.

M-319 Continued Increase of Azole Resistance in Aspergillus fumiga- tus Af in Dutch Hospitals D. Versteeg, E. Snelders, T. Rijs, BSc - research, W. Melchers, P. Verweij; Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands. M-320 Development of Resistance to Agricultural Azole Antifungal Compounds: Emergence of Multidrug Cross-Resistance Among Human Fungal Pathogens Candida, Cryptococcus and Aspergillus I. Faria-Ramos 1 , S. Farinha 1 , P. Tavares 1 , J. Maia 1 , E. Ricardo 1,2 , I. M. Miranda 1,2 , C. Pina-Vaz 1,2,3 , A. G. Rodrigues 1,2,3 ; 1 Univ. of Porto, Oporto, Portugal, 2 Cardiovascular Res. Dev. Unit, Faculty of Med., Univ. of Porto, Porto, Portugal, 3 Hosp. S. João, Porto, Portugal. M-321 Population-Based Program of Aspergillus spp. Antifungal Resistance in Spain FILPOP STUDY A. Alastruey-Izquierdo 1 , E. Mellado 1 , T. Pelaez 2 , J. Peman 3 , S. Zapico 4 , M. Alvarez 5 , M. Cuenca-Estrella 1 , FILPOP Study Group; 1 Centro Nacio- nal de Microbiologia, ISCIII, Majadahonda. Madrid, Spain, 2 Hosp. Gregorio Marañón, Madrid, Spain, 3 Hosp. La Fe, Valencia, Spain, 4 Hosp. de Donostia, Guipuzcoa, Spain, 5 Hosp. Central de Asturias, Oviedo, Spain. M-322 Epidemiology of Otomycosis in a Large Teaching Hospital Over a 24-Year Period: Is There Any Difference Between Adult and Pediatric Patients? T. Peláez, S. Álvarez-Pérez, L. Alcalá, B. Gama, BSc, F. Romero, E. Bouza; Hosp. Gen. Univ. Gregorio Marañón, Madrid, Spain. M-323 Emerging Trends in Candidemia by C. glabrata: A Better Out- come in a Worse Setting Withdrawn M-324 Influence of Voriconazole VRC on Survival Outcome of Trichosporonemia: Result Epidemiological Study in Japan I. Tokimatsu, H. Kushima, S. Toba, J. Kadota, Japan Trichosporonosis Study Group; Oita Univ. Faculty of Med., Yufu, Japan. M-325 Risk Factors and Epidemiology of Candidemia by Candida guilliermondii

Y. Yamagishi, H. Mikamo; Aichi Med. Univ., Aichi, Japan. M-326

The Defined Daily Dose DDD of Micafungin Usage Didn’t Affect Incidence of Candida parapsilosis Candidemia at Tertiary Hospital in Japan Y. Hirai, S. Asahata, Y. Ainoda, H. Konishi, K. Okada, T. Fujita, K. Totsuka; Tokyo Women’s Med. Univ., Tokyo, Japan. M-327 Species Distribution and Susceptibility Profile of Yeasts Isolated from Blood Cultures: Preliminary Results of a Multi- center Study for Latin America

S. Córdoba